Log In
Print this Print this

Buspar, buspirone

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
Molecular Target Serotonin (5-HT1A) receptor
Mechanism of ActionSerotonin (5-HT1A) receptor partial agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnxiety
Indication DetailsTreat general anxiety disorder (GAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today